AcrySof Toric Clinical Results

This study has been completed.
Information provided by (Responsible Party):
Alcon Research Identifier:
First received: August 7, 2008
Last updated: September 27, 2012
Last verified: October 2010

This study is an evaluation of visual outcomes of subjects implanted with the AcrySof Toric Intraocular Lenses (IOLs) Models SN60T3, SN60T4, and SN60T5.

Condition Intervention Phase
Device: T3
Device: T4
Device: T5
Phase 4

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Clinical Results With the AcrySof Toric Intraocular Lens (IOL)

Resource links provided by NLM:

Further study details as provided by Alcon Research:

Primary Outcome Measures:
  • Visual Acuity [ Time Frame: 1 day to 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Postoperative refractive cylinder [ Time Frame: 1day to 6 months ] [ Designated as safety issue: No ]

Enrollment: 144
Study Start Date: August 2007
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Model SN60T3 assigned by AcrySof Toric calculator
Device: T3
Implantation of the AcrySof Toric Intraocular Lens (IOL) Model SN60T3
Model SN60T4 assigned by AcrySof Toric calculator
Device: T4
Implantation of the AcrySof Toric Intraocular Lens (IOL) Model SN60T4
Model SN60T5 assigned by AcrySof Toric calculator
Device: T5
Implantation of the AcrySof Toric Intraocular Lens (IOL) Model SN60T5


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Study population chosen from physician's patients implanted with the AcrySof Toric intraocular lens (IOL)


Inclusion Criteria:

  • Diagnosed with cataracts; has astigmatism falling in range of AcrySof Toric lens as assessed by the AcrySof Toric calculator

Exclusion Criteria:

  • Ocular comorbidities affecting visual outcome data,
  • Prior refractive surgery,
  • Irregular astigmatism
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01214863

United States, Texas
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research
  More Information

No publications provided

Responsible Party: Alcon Research Identifier: NCT01214863     History of Changes
Other Study ID Numbers: M07-007
Study First Received: August 7, 2008
Last Updated: September 27, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Alcon Research:
Toric Intraocular Lens (IOL)

Additional relevant MeSH terms:
Eye Diseases
Refractive Errors processed this record on October 30, 2014